Induction of the Unfolded Protein Response by Brucella abortus VceC
流产布鲁氏菌 VceC 诱导未折叠蛋白反应
基本信息
- 批准号:8920474
- 负责人:
- 金额:$ 38.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgonistAnimal ModelAnimalsBrucellaBrucella abortusBrucella melitensisBrucellosisCellsConsumptionCytosolDairy ProductsDataDetectionDiseaseDisease OutcomeEndoplasmic ReticulumFeverGenesGoalsHealthImmuneImmune responseImmune systemInduced AbortionInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInjection of therapeutic agentInsulin-Dependent Diabetes MellitusLeadLinkMicrobeMolecularMolecular ChaperonesNF-kappa BNatural ImmunityOutcomePathogen detectionPathogenesisPathway interactionsPatternPattern RecognitionPattern recognition receptorProcessProteinsSignal PathwayStructureTestingTissuesType IV Secretion System PathwayVirulence FactorsVirus DiseasesWorkZoonotic Infectionabortionbasein vivoinnovationmicrobialpathogenresponsetransmission processunpasteurizedvirus host interaction
项目摘要
DESCRIPTION (provided by applicant): The innate immune system detects the presence of microbes in tissue by pattern recognition of conserved microbial structures, known as pathogen-associated molecular patterns (PAMPs). However PAMPs can be present in all microbes regardless of their pathogenic potential. To distinguish pathogens from other microbes with lower disease-causing potential the innate immune system can detect pathogen-induced processes, such as the presence of microbial products in the host cell cytosol, through mechanisms that are not fully resolved. Identification of signaling pathways involved in the detection of pathogen-induced processes is often difficult because PAMPs expressed by a pathogen can activate many pattern recognition receptors in parallel. Brucella abortus is a stealthy pathogen expressing modified PAMPs that no longer serve as agonists for pattern recognition receptors. As a result, host responses generated during B. abortus infection are entirely dependent on detecting the deployment of a virulence factor, the type IV secretion system (T4SS), as a pathogen-induced process. Here we propose to use this model organism to define a new signaling pathway involved in sensing the T4SS-dependent injection of proteins into the host cell cytosol as a pathogen-induced process. Our long-range goal is to determine the mechanisms and consequences of inducing inflammatory host responses during B. abortus infection. The objectives of this application are to study how translocation of the T4SS substrate VceC into host cells induces pro-inflammatory responses and alters the disease outcome. We hypothesize that translocation of the T4SS substrate VceC activates the unfolded protein response (UPR) with consequent induction of NF-κB-dependent inflammatory responses, thereby contributing to B. abortus- induced abortion. We will test key aspects of our hypothesis and accomplish the objectives of this application by pursuing two specific aims: (1) Elucidate the signaling pathway that detects targeting of VceC to the endoplasmic reticulum; and (2) Characterize the mechanism by which the UPR activates inflammatory responses in vivo. Successful completion of this work will move the field forward by establishing the UPR as a component of the innate immune system that detects microbial proteins targeting the ER as a pathogen- induced process. This new concept has important ramifications not only for bacterial pathogenesis, but also for host-virus interactions, innate immunity and the pathogenesis of certain inflammatory disorders, such as type 1 diabetes and inflammatory bowel disease.
描述(由申请人提供):先天免疫系统通过保守微生物结构的模式识别(称为病原体相关分子模式(PAMP))来检测组织中微生物的存在,但是 PAMP 可以存在于所有微生物中,无论其致病潜力如何。为了将病原体与其他致病潜力较低的微生物区分开来,先天免疫系统可以通过以下机制检测病原体诱导的过程,例如宿主细胞胞质中是否存在微生物产物。鉴定参与病原体诱导过程检测的信号通路通常很困难,因为病原体表达的 PAMP 可以同时激活许多模式识别受体,流产布鲁氏菌是一种表达修饰的 PAMP 的隐秘病原体,而这些受体不再发挥作用。因此,流产布鲁氏菌感染期间产生的宿主反应完全依赖于检测作为病原体诱导的毒力因子,即 IV 型分泌系统 (T4SS) 的部署。在这里,我们建议使用这种模型生物来定义一个新的信号通路,该通路参与感知 T4SS 依赖性蛋白质注射到宿主细胞胞质中作为病原体诱导的过程。我们的长期目标是确定其机制和后果。本申请的目的是研究 T4SS 底物 VceC 转位到宿主细胞中如何诱导促炎症反应并改变疾病结果。激活未折叠蛋白反应 (UPR),随后诱导 NF-κB 依赖性炎症反应,从而导致流产巴氏杆菌引起的流产。我们将测试我们假设的关键方面,并通过追求两个特定目标来实现本申请的目标。 :(1)阐明检测VceC靶向内质网的信号通路;(2)表征UPR激活体内炎症反应的机制。通过将 UPR 建立为先天免疫系统的一个组成部分,该系统可检测针对 ER 的微生物蛋白作为病原体诱导的过程,从而推动该领域向前发展。这一新概念不仅对细菌发病机制,而且对宿主与病毒的相互作用也具有重要影响。先天免疫和某些炎症性疾病的发病机制,例如 1 型糖尿病和炎症性肠病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Renee M Tsolis其他文献
Brucella melitensis Rev1Δwzm: Placental pathogenesis studies and safety in pregnant ewes.
羊布鲁氏菌Rev1Îwzm:怀孕母羊的胎盘发病机制研究和安全性。
- DOI:
10.1016/j.vaccine.2024.04.085 - 发表时间:
2024-05-01 - 期刊:
- 影响因子:5.5
- 作者:
I. Poveda;S. Mena;G. A. Ramírez;A. Zabalza;Renee M Tsolis;María - 通讯作者:
María
Renee M Tsolis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Renee M Tsolis', 18)}}的其他基金
2023 Salmonella Biology and Pathogenesis Gordon Research Conference and Seminar
2023年沙门氏菌生物学与发病机制戈登研究会议暨研讨会
- 批准号:
10683617 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
2023 Salmonella Biology and Pathogenesis Gordon Research Conference and Seminar
2023年沙门氏菌生物学与发病机制戈登研究会议暨研讨会
- 批准号:
10683617 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Neutrophil-intrinsic role of SLC11A1/NRAMP1 in control of bacterial infection
SLC11A1/NRAMP1 在控制细菌感染中的中性粒细胞内在作用
- 批准号:
10224776 - 财政年份:2019
- 资助金额:
$ 38.37万 - 项目类别:
Neutrophil-intrinsic role of SLC11A1/NRAMP1 in control of bacterial infection
SLC11A1/NRAMP1 在控制细菌感染中的中性粒细胞内在作用
- 批准号:
10683118 - 财政年份:2019
- 资助金额:
$ 38.37万 - 项目类别:
Neutrophil-intrinsic role of SLC11A1/NRAMP1 in control of bacterial infection
SLC11A1/NRAMP1 在控制细菌感染中的中性粒细胞内在作用
- 批准号:
10755395 - 财政年份:2019
- 资助金额:
$ 38.37万 - 项目类别:
Neutrophil-intrinsic role of SLC11A1/NRAMP1 in control of bacterial infection
SLC11A1/NRAMP1 在控制细菌感染中的中性粒细胞内在作用
- 批准号:
10022095 - 财政年份:2019
- 资助金额:
$ 38.37万 - 项目类别:
Neutrophil-intrinsic role of SLC11A1/NRAMP1 in control of bacterial infection
SLC11A1/NRAMP1 在控制细菌感染中的中性粒细胞内在作用
- 批准号:
10468025 - 财政年份:2019
- 资助金额:
$ 38.37万 - 项目类别:
2019 Microbial Adhesion and Signal Transduction GRC/GRS
2019微生物粘附与信号转导GRC/GRS
- 批准号:
9752745 - 财政年份:2019
- 资助金额:
$ 38.37万 - 项目类别:
Neutrophil-intrinsic role of SLC11A1/NRAMP1 in control of bacterial infection
SLC11A1/NRAMP1 在控制细菌感染中的中性粒细胞内在作用
- 批准号:
10772361 - 财政年份:2019
- 资助金额:
$ 38.37万 - 项目类别:
Systemic infections with non-typhoidal Salmonella
非伤寒沙门氏菌全身感染
- 批准号:
9238432 - 财政年份:2016
- 资助金额:
$ 38.37万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
脆性X综合征动物模型中异常视觉信息处理和视觉注意力的神经环路机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Optogenetic and chemogenetic regulation of uterine vascular function
子宫血管功能的光遗传学和化学遗传学调控
- 批准号:
10785667 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Targeting Cholesterol Homeostasis to maintain vision in MS-like optic neuritis
针对多发性硬化症样视神经炎的胆固醇稳态以维持视力
- 批准号:
10657163 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent Arrhythmias
RyR 激动剂部分且受控地消耗 SR 钙可预防钙依赖性心律失常
- 批准号:
10577630 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Protease-activated-receptor-2 antagonists for treatment of migraine pain
蛋白酶激活受体 2 拮抗剂治疗偏头痛
- 批准号:
10602826 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
- 批准号:
10603408 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别: